Belvedere Trading’s Vera Therapeutics VERA Stock Holding History

Belvedere Trading’s Portfolio VERA Stock Details VERA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-1,500	Closed	-$64.7K	–	925
2024 Q1	$64.7K	Buy	+1,500	New	+$53.5K	﹤0.01%	481

Other funds holding VERA

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Belvedere Trading's VERA Position: Q3 2025 in Review

Belvedere Trading sold out of Vera Therapeutics (VERA) in Q3 2025, closing a stake of 6,817 shares — an estimated $161K sold.

Belvedere Trading first reported a position in VERA in Q1 2024 and held it in 3 quarters. The position peaked at $191K in Q2 2024. 175 funds tracked by Wall St. Rank hold VERA as of Q3 2025.

Belvedere Trading reported no remaining Vera Therapeutics position as of Q3 2025 after selling out during the quarter.
Belvedere Trading sold 6,817 Vera Therapeutics shares in Q3 2025, an estimated $161K.
Belvedere Trading first reported a position in Vera Therapeutics in Q1 2024 and held it in 3 quarters.
Belvedere Trading's Vera Therapeutics position peaked at $191K in Q2 2024.
175 funds tracked by Wall St. Rank held Vera Therapeutics as of Q3 2025.

Based on Belvedere Trading's 13F filing for Q3 2025, filed 27 Oct 2025.